Ethosuximide
Active substance: ethosuximide
SOLUTION · ETHOSUXIMIDE 250 mg/5mL
United StatesActive
Marketing holder: Mylan Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
- ETHOSUXIMIDE · 250 mg/5mL
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 7 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-4865-70ab-8a76-eed7e7da3cd3,01a120c3-9f0a-75cc-a5a5-886cf04d65c6,01a120c3-a194-72cd-ae00-6cf2ce401076,01a120c4-d652-7db8-9989-228a8a001c69,01a120c5-2768-7d14-967a-ef01b5af85e7;count=7 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-8202-7422-8f90-295205c06e3f,01a1208d-17fe-7b12-8617-f133082d8c1a,01a1208d-5ef3-7da7-8d80-1c9230aca682,01a1208d-f8d8-7d9e-a838-9cf021742c9a,01a1208e-9821-71b2-ac0c-74241152faa8;count=12 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 59762-2350
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
- product · openFDA NDC · 59762-2350 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 59762-2350 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 59762-2350 · Verified 2026-10-09 · open in source